Clinical trials
Phase 3 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 12 |
| Unknown status | 9 |
| Terminated | 7 |
| Active, not recruiting | 5 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 4 |
| M.D. Anderson Cancer Center | 4 |
| Novartis Pharmaceuticals | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Children's Oncology Group | 3 |
| Ottawa Hospital Research Institute | 3 |
| Alliance for Clinical Trials in Oncology | 2 |
| Gamida Cell ltd | 2 |
| Mayo Clinic | 2 |
| Merck Sharp & Dohme LLC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 65 |
| Leukemia | 6 |
| Multiple Myeloma | 6 |
| Myelodysplastic Syndromes | 6 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Neoplasms | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.